 | • レポートコード：MRC2Q12-00944 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、抗菌活性ペプチドのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 抗菌活性ペプチドのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗菌活性ペプチドの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗菌活性ペプチドのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの抗菌活性ペプチドの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の抗菌活性ペプチドの売上および2028年までの予測に焦点を当てています。 抗菌活性ペプチドのグローバル主要企業には、Antimicrobial peptides、Genscript、Pepscan、CPC Scientific、ALLVIVO VASCULAR, INC.、Matrubials、ContraFect Corporation、Lytica Therapeutics、Lytix Biopharma AS、Ingenza、ReAlta Life Sciences、Celdara Medical、Peptilogics、MaxWell Biosciences、Numafermなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗菌活性ペプチド市場は、タイプとアプリケーションによって区分されます。世界の抗菌活性ペプチド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 微生物抗菌ペプチド、植物抗菌ペプチド、動物抗菌ペプチド、その他 【アプリケーション別セグメント】 食品、医療、動物性食品、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗菌活性ペプチド製品概要 - タイプ別市場（微生物抗菌ペプチド、植物抗菌ペプチド、動物抗菌ペプチド、その他） - アプリケーション別市場（食品、医療、動物性食品、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の抗菌活性ペプチド販売量予測2017-2028 - 世界の抗菌活性ペプチド売上予測2017-2028 - 抗菌活性ペプチドの地域別販売量 - 抗菌活性ペプチドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗菌活性ペプチド販売量 - 主要メーカー別抗菌活性ペプチド売上 - 主要メーカー別抗菌活性ペプチド価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（微生物抗菌ペプチド、植物抗菌ペプチド、動物抗菌ペプチド、その他） - 抗菌活性ペプチドのタイプ別販売量 - 抗菌活性ペプチドのタイプ別売上 - 抗菌活性ペプチドのタイプ別価格 ・アプリケーション別市場規模（食品、医療、動物性食品、その他） - 抗菌活性ペプチドのアプリケーション別販売量 - 抗菌活性ペプチドのアプリケーション別売上 - 抗菌活性ペプチドのアプリケーション別価格 ・北米市場 - 北米の抗菌活性ペプチド市場規模（タイプ別、アプリケーション別） - 主要国別の抗菌活性ペプチド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗菌活性ペプチド市場規模（タイプ別、アプリケーション別） - 主要国別の抗菌活性ペプチド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗菌活性ペプチド市場規模（タイプ別、アプリケーション別） - 主要国別の抗菌活性ペプチド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗菌活性ペプチド市場規模（タイプ別、アプリケーション別） - 主要国別の抗菌活性ペプチド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗菌活性ペプチド市場規模（タイプ別、アプリケーション別） - 主要国別の抗菌活性ペプチド市場規模（トルコ、サウジアラビア） ・企業情報 Antimicrobial peptides、Genscript、Pepscan、CPC Scientific、ALLVIVO VASCULAR, INC.、Matrubials、ContraFect Corporation、Lytica Therapeutics、Lytix Biopharma AS、Ingenza、ReAlta Life Sciences、Celdara Medical、Peptilogics、MaxWell Biosciences、Numaferm ・産業チェーン及び販売チャネル分析 - 抗菌活性ペプチドの産業チェーン分析 - 抗菌活性ペプチドの原材料 - 抗菌活性ペプチドの生産プロセス - 抗菌活性ペプチドの販売及びマーケティング - 抗菌活性ペプチドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗菌活性ペプチドの産業動向 - 抗菌活性ペプチドのマーケットドライバー - 抗菌活性ペプチドの課題 - 抗菌活性ペプチドの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antibacterial Active Peptide estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Antibacterial Active Peptide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Antibacterial Active Peptide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Antibacterial Active Peptide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Antibacterial Active Peptide include Antimicrobial peptides, Genscript, Pepscan, CPC Scientific, ALLVIVO VASCULAR, INC., Matrubials, ContraFect Corporation, Lytica Therapeutics and Lytix Biopharma AS, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Antibacterial Active Peptide production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Antibacterial Active Peptide by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antibacterial Active Peptide manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Antibacterial Active Peptide market. Further, it explains the major drivers and regional dynamics of the global Antibacterial Active Peptide market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Antimicrobial peptides
Genscript
Pepscan
CPC Scientific
ALLVIVO VASCULAR, INC.
Matrubials
ContraFect Corporation
Lytica Therapeutics
Lytix Biopharma AS
Ingenza
ReAlta Life Sciences
Celdara Medical
Peptilogics
MaxWell Biosciences
Numaferm
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Antibacterial Active Peptide Segment by Type
Microbial Antimicrobial Peptides
Plant Antimicrobial Peptides
Animal Antimicrobial Peptides
Others
Antibacterial Active Peptide Segment by Application
Food
Medical
Animal Food
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Antibacterial Active Peptide production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antibacterial Active Peptide market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Antibacterial Active Peptide, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Antibacterial Active Peptide, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Antibacterial Active Peptide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibacterial Active Peptide sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Antibacterial Active Peptide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Antibacterial Active Peptide sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Antimicrobial peptides, Genscript, Pepscan, CPC Scientific, ALLVIVO VASCULAR, INC., Matrubials, ContraFect Corporation, Lytica Therapeutics and Lytix Biopharma AS, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Antibacterial Active Peptide capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Antibacterial Active Peptide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Antibacterial Active Peptide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibacterial Active Peptide sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Antibacterial Active Peptide Product Introduction
1.2 Market by Type
1.2.1 Global Antibacterial Active Peptide Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Microbial Antimicrobial Peptides
1.2.3 Plant Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibacterial Active Peptide Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Food
1.3.3 Medical
1.3.4 Animal Food
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Antibacterial Active Peptide Production
2.1 Global Antibacterial Active Peptide Production Capacity (2017-2028)
2.2 Global Antibacterial Active Peptide Production by Region: 2017 VS 2021 VS 2028
2.3 Global Antibacterial Active Peptide Production by Region
2.3.1 Global Antibacterial Active Peptide Historic Production by Region (2017-2022)
2.3.2 Global Antibacterial Active Peptide Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Antibacterial Active Peptide Sales in Volume & Value Estimates and Forecasts
3.1 Global Antibacterial Active Peptide Sales Estimates and Forecasts 2017-2028
3.2 Global Antibacterial Active Peptide Revenue Estimates and Forecasts 2017-2028
3.3 Global Antibacterial Active Peptide Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Antibacterial Active Peptide Sales by Region
3.4.1 Global Antibacterial Active Peptide Sales by Region (2017-2022)
3.4.2 Global Sales Antibacterial Active Peptide by Region (2023-2028)
3.5 Global Antibacterial Active Peptide Revenue by Region
3.5.1 Global Antibacterial Active Peptide Revenue by Region (2017-2022)
3.5.2 Global Antibacterial Active Peptide Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Antibacterial Active Peptide Production Capacity by Manufacturers
4.2 Global Antibacterial Active Peptide Sales by Manufacturers
4.2.1 Global Antibacterial Active Peptide Sales by Manufacturers (2017-2022)
4.2.2 Global Antibacterial Active Peptide Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Antibacterial Active Peptide in 2021
4.3 Global Antibacterial Active Peptide Revenue by Manufacturers
4.3.1 Global Antibacterial Active Peptide Revenue by Manufacturers (2017-2022)
4.3.2 Global Antibacterial Active Peptide Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Antibacterial Active Peptide Revenue in 2021
4.4 Global Antibacterial Active Peptide Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Antibacterial Active Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Antibacterial Active Peptide Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Antibacterial Active Peptide Sales by Type
5.1.1 Global Antibacterial Active Peptide Historical Sales by Type (2017-2022)
5.1.2 Global Antibacterial Active Peptide Forecasted Sales by Type (2023-2028)
5.1.3 Global Antibacterial Active Peptide Sales Market Share by Type (2017-2028)
5.2 Global Antibacterial Active Peptide Revenue by Type
5.2.1 Global Antibacterial Active Peptide Historical Revenue by Type (2017-2022)
5.2.2 Global Antibacterial Active Peptide Forecasted Revenue by Type (2023-2028)
5.2.3 Global Antibacterial Active Peptide Revenue Market Share by Type (2017-2028)
5.3 Global Antibacterial Active Peptide Price by Type
5.3.1 Global Antibacterial Active Peptide Price by Type (2017-2022)
5.3.2 Global Antibacterial Active Peptide Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Antibacterial Active Peptide Sales by Application
6.1.1 Global Antibacterial Active Peptide Historical Sales by Application (2017-2022)
6.1.2 Global Antibacterial Active Peptide Forecasted Sales by Application (2023-2028)
6.1.3 Global Antibacterial Active Peptide Sales Market Share by Application (2017-2028)
6.2 Global Antibacterial Active Peptide Revenue by Application
6.2.1 Global Antibacterial Active Peptide Historical Revenue by Application (2017-2022)
6.2.2 Global Antibacterial Active Peptide Forecasted Revenue by Application (2023-2028)
6.2.3 Global Antibacterial Active Peptide Revenue Market Share by Application (2017-2028)
6.3 Global Antibacterial Active Peptide Price by Application
6.3.1 Global Antibacterial Active Peptide Price by Application (2017-2022)
6.3.2 Global Antibacterial Active Peptide Price Forecast by Application (2023-2028)
7 North America
7.1 North America Antibacterial Active Peptide Market Size by Type
7.1.1 North America Antibacterial Active Peptide Sales by Type (2017-2028)
7.1.2 North America Antibacterial Active Peptide Revenue by Type (2017-2028)
7.2 North America Antibacterial Active Peptide Market Size by Application
7.2.1 North America Antibacterial Active Peptide Sales by Application (2017-2028)
7.2.2 North America Antibacterial Active Peptide Revenue by Application (2017-2028)
7.3 North America Antibacterial Active Peptide Sales by Country
7.3.1 North America Antibacterial Active Peptide Sales by Country (2017-2028)
7.3.2 North America Antibacterial Active Peptide Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Antibacterial Active Peptide Market Size by Type
8.1.1 Europe Antibacterial Active Peptide Sales by Type (2017-2028)
8.1.2 Europe Antibacterial Active Peptide Revenue by Type (2017-2028)
8.2 Europe Antibacterial Active Peptide Market Size by Application
8.2.1 Europe Antibacterial Active Peptide Sales by Application (2017-2028)
8.2.2 Europe Antibacterial Active Peptide Revenue by Application (2017-2028)
8.3 Europe Antibacterial Active Peptide Sales by Country
8.3.1 Europe Antibacterial Active Peptide Sales by Country (2017-2028)
8.3.2 Europe Antibacterial Active Peptide Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antibacterial Active Peptide Market Size by Type
9.1.1 Asia Pacific Antibacterial Active Peptide Sales by Type (2017-2028)
9.1.2 Asia Pacific Antibacterial Active Peptide Revenue by Type (2017-2028)
9.2 Asia Pacific Antibacterial Active Peptide Market Size by Application
9.2.1 Asia Pacific Antibacterial Active Peptide Sales by Application (2017-2028)
9.2.2 Asia Pacific Antibacterial Active Peptide Revenue by Application (2017-2028)
9.3 Asia Pacific Antibacterial Active Peptide Sales by Region
9.3.1 Asia Pacific Antibacterial Active Peptide Sales by Region (2017-2028)
9.3.2 Asia Pacific Antibacterial Active Peptide Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Antibacterial Active Peptide Market Size by Type
10.1.1 Latin America Antibacterial Active Peptide Sales by Type (2017-2028)
10.1.2 Latin America Antibacterial Active Peptide Revenue by Type (2017-2028)
10.2 Latin America Antibacterial Active Peptide Market Size by Application
10.2.1 Latin America Antibacterial Active Peptide Sales by Application (2017-2028)
10.2.2 Latin America Antibacterial Active Peptide Revenue by Application (2017-2028)
10.3 Latin America Antibacterial Active Peptide Sales by Country
10.3.1 Latin America Antibacterial Active Peptide Sales by Country (2017-2028)
10.3.2 Latin America Antibacterial Active Peptide Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Antibacterial Active Peptide Market Size by Type
11.1.1 Middle East and Africa Antibacterial Active Peptide Sales by Type (2017-2028)
11.1.2 Middle East and Africa Antibacterial Active Peptide Revenue by Type (2017-2028)
11.2 Middle East and Africa Antibacterial Active Peptide Market Size by Application
11.2.1 Middle East and Africa Antibacterial Active Peptide Sales by Application (2017-2028)
11.2.2 Middle East and Africa Antibacterial Active Peptide Revenue by Application (2017-2028)
11.3 Middle East and Africa Antibacterial Active Peptide Sales by Country
11.3.1 Middle East and Africa Antibacterial Active Peptide Sales by Country (2017-2028)
11.3.2 Middle East and Africa Antibacterial Active Peptide Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Antimicrobial peptides
12.1.1 Antimicrobial peptides Corporation Information
12.1.2 Antimicrobial peptides Overview
12.1.3 Antimicrobial peptides Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Antimicrobial peptides Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Antimicrobial peptides Recent Developments
12.2 Genscript
12.2.1 Genscript Corporation Information
12.2.2 Genscript Overview
12.2.3 Genscript Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Genscript Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Genscript Recent Developments
12.3 Pepscan
12.3.1 Pepscan Corporation Information
12.3.2 Pepscan Overview
12.3.3 Pepscan Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Pepscan Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Pepscan Recent Developments
12.4 CPC Scientific
12.4.1 CPC Scientific Corporation Information
12.4.2 CPC Scientific Overview
12.4.3 CPC Scientific Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 CPC Scientific Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 CPC Scientific Recent Developments
12.5 ALLVIVO VASCULAR, INC.
12.5.1 ALLVIVO VASCULAR, INC. Corporation Information
12.5.2 ALLVIVO VASCULAR, INC. Overview
12.5.3 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 ALLVIVO VASCULAR, INC. Recent Developments
12.6 Matrubials
12.6.1 Matrubials Corporation Information
12.6.2 Matrubials Overview
12.6.3 Matrubials Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Matrubials Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Matrubials Recent Developments
12.7 ContraFect Corporation
12.7.1 ContraFect Corporation Corporation Information
12.7.2 ContraFect Corporation Overview
12.7.3 ContraFect Corporation Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 ContraFect Corporation Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 ContraFect Corporation Recent Developments
12.8 Lytica Therapeutics
12.8.1 Lytica Therapeutics Corporation Information
12.8.2 Lytica Therapeutics Overview
12.8.3 Lytica Therapeutics Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Lytica Therapeutics Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Lytica Therapeutics Recent Developments
12.9 Lytix Biopharma AS
12.9.1 Lytix Biopharma AS Corporation Information
12.9.2 Lytix Biopharma AS Overview
12.9.3 Lytix Biopharma AS Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Lytix Biopharma AS Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Lytix Biopharma AS Recent Developments
12.10 Ingenza
12.10.1 Ingenza Corporation Information
12.10.2 Ingenza Overview
12.10.3 Ingenza Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Ingenza Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Ingenza Recent Developments
12.11 ReAlta Life Sciences
12.11.1 ReAlta Life Sciences Corporation Information
12.11.2 ReAlta Life Sciences Overview
12.11.3 ReAlta Life Sciences Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 ReAlta Life Sciences Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 ReAlta Life Sciences Recent Developments
12.12 Celdara Medical
12.12.1 Celdara Medical Corporation Information
12.12.2 Celdara Medical Overview
12.12.3 Celdara Medical Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Celdara Medical Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Celdara Medical Recent Developments
12.13 Peptilogics
12.13.1 Peptilogics Corporation Information
12.13.2 Peptilogics Overview
12.13.3 Peptilogics Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Peptilogics Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Peptilogics Recent Developments
12.14 MaxWell Biosciences
12.14.1 MaxWell Biosciences Corporation Information
12.14.2 MaxWell Biosciences Overview
12.14.3 MaxWell Biosciences Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 MaxWell Biosciences Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 MaxWell Biosciences Recent Developments
12.15 Numaferm
12.15.1 Numaferm Corporation Information
12.15.2 Numaferm Overview
12.15.3 Numaferm Antibacterial Active Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Numaferm Antibacterial Active Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Numaferm Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Antibacterial Active Peptide Industry Chain Analysis
13.2 Antibacterial Active Peptide Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Antibacterial Active Peptide Production Mode & Process
13.4 Antibacterial Active Peptide Sales and Marketing
13.4.1 Antibacterial Active Peptide Sales Channels
13.4.2 Antibacterial Active Peptide Distributors
13.5 Antibacterial Active Peptide Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Antibacterial Active Peptide Industry Trends
14.2 Antibacterial Active Peptide Market Drivers
14.3 Antibacterial Active Peptide Market Challenges
14.4 Antibacterial Active Peptide Market Restraints
15 Key Finding in The Global Antibacterial Active Peptide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer